Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

被引:9
|
作者
Silano, Julia A. [1 ]
Treloar, Carla [2 ]
Leadbeatter, Kyle [3 ]
Davidson, Sandy [3 ]
Doidge, Justine [3 ]
机构
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ New South Wales, Sydney, NSW, Australia
[3] Hepatitis NSW, Sydney, NSW, Australia
关键词
Hepatitis C; Peer workers; Socially marginalised groups; Community-based HCV care; INJECT DRUGS; VIRUS; PEOPLE; CARE; ELIMINATION; AUSTRALIA; SERVICES; BARRIERS;
D O I
10.1186/s12954-022-00619-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts. Case presentation The LHCF project aims to facilitate access to on-the-spot HCV testing, treatment, and care in priority settings through partnership between a peer worker (PW) and a clinical nurse. Since the start of the project in January 2018, 4515 people were engaged about HCV and encouraged to access on-site HCV health care, and over 1000 people were screened for HCV and liver health, while almost 250 people accessed HCV treatment through the project. This commentary is intended to prompt discussion about incorporating peer-centred HCV health programs into priority sites. HCV care-delivery models such as the LHCF project can continue to contribute to micro-elimination of HCV in key settings to increase treatment uptake amongst high prevalence and/or marginalised populations and support progress toward national elimination targets. Conclusions The LHCF project has been able to highlight the benefits of incorporating trustworthy, efficient, and convenient peer-centred health services to engage and support vulnerable populations through HCV testing and treatment, particularly individuals who have historically been disconnected from the health care system. Additional attention is needed to ensure ongoing funding support to sustain the project and deliver at scale and in expanding evaluation data to examine the operation and outcomes of the project in more detail.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Pediatric Hepatitis C Quality Improvement Project Improves Healthcare Access
    Vallabhan, Monique K.
    Castillo, Ricardo
    Roldan, Patricia
    Rhoades, Natalie
    Kong, Alberta S.
    Jimenez, Elizabeth Y.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (03): : 371 - 378
  • [32] Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion
    Chu, Carissa E.
    Wu, Feng
    He, Xi
    Zhou, Kali
    Cheng, Yu
    Cai, Weiping
    Geng, Elvin
    Volberding, Paul
    Tucker, Joseph D.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (02):
  • [33] 'C' the potential: needle and syringe programs as hepatitis C treatment sites
    Miller, Kathleen
    Sheaves, Felicity
    Maher, Louise
    Page, Julie
    Bridges-Webb, Ian
    Treloar, Carla
    DRUGS-EDUCATION PREVENTION AND POLICY, 2020, 27 (01) : 92 - 94
  • [34] Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment
    Brener, Loren
    Treloar, Carla J.
    AUSTRALIAN HEALTH REVIEW, 2009, 33 (01) : 100 - 106
  • [35] Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine
    Talal, Andrew H.
    Markatou, Marianthi
    Liu, Anran
    Perumalswami, Ponni V.
    Dinani, Amreen M.
    Tobin, Jonathan N.
    Brown, Lawrence S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (16): : 1369 - 1378
  • [36] Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS
    Ford, Nathan
    Singh, Kasha
    Cooke, Graham S.
    Mills, Edward J.
    von Schoen-Angerer, Tido
    Kamarulzaman, Adeeba
    du Cros, Philipp
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (10) : 1465 - 1472
  • [37] Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C)
    Rance, Jake
    Lafferty, Lise
    Treloar, Carla
    HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [38] Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination
    Brown, Graham
    Perry, Gari-Emma
    Byrne, Jude
    Crawford, Sione
    Henderson, Charles
    Madden, Annie
    Lobo, Roanna
    Reeders, Daniel
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 72 : 24 - 32
  • [39] Role of peer support in a hepatitis C elimination programme
    Jugnarain, Davina Varsha
    Halford, Rachel
    Smith, Stuart
    Hickman, Matthew
    Samartsidis, Pantelis
    Foster, Graham R.
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (01) : 43 - 51
  • [40] The Hepatitis C virus treatment cascade at an urban postincarceration transitions clinic
    Hawks, L.
    Norton, B. L.
    Cunningham, C. O.
    Fox, A. D.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (06) : 473 - 478